NCT02813551View on ClinicalTrials.gov

ToRsemide for pOstpartum HYpertension

PHASE2CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

July 28, 2017

Study Completion Date

September 9, 2017

Conditions
Preeclampsia
Interventions
DRUG

Torsemide

DRUG

Placebo

Trial Locations (1)

77030

The University of Texas Health Science Center, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER

NCT02813551 - ToRsemide for pOstpartum HYpertension | Biotech Hunter | Biotech Hunter